Loading…
Loading…
BOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced the addition of Kevin Williams as an Academic Affiliate in the firm's Antitrust & Competition Economics Practice. “I am pleased to welcome Kevin to CRA,” said Paul Maleh, President and Chief Executive Officer of Charles River Associates. “Kevin is a recognized expert in the economics of industrial organization, with a focu.
Investors need to pay close attention to CRAI stock based on the movements in the options market lately.
Charles River Associates' global talent network, cross-border expertise, and rising dividends and buybacks support long-term growth and enhance investor appeal.
PHILADELPHIA and VANCOUVER, British Columbia, July 07, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, today announced that it has engaged Charles River Associates (CRA) (Nasdaq: CRAI) and Kaleio, Inc. to support commercial strategy, market access evaluation and brand planning for Bria-IMT.
CRAI benefits from rising demand for specialized advisory services, but AI, talent costs and fierce competition pose risks.
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
Rising talent costs, persistent inflation and cautious corporate spending are weighing on the consulting services industry. Expert consultation and data-driven advisory demand are likely to aid.
[url="]Charles River Associates[/url] (NASDAQ: CRAI), a worldwide leader in providing [url="]economic, financial, and management consulting services[/url], tod
Full call transcripts — prepared remarks + analyst Q&A — with speaker-by-speaker formatting and one-click switching across every quarter on file.
Click below to see what's inside, then upgrade to read every transcript for CRAI and 80,000+ other tickers.
Transcripts source: company-published earnings calls. Speaker attribution and formatting are processed in-app.